Enanta Pharma (ENTA) Tops Q4 EPS by 5c

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
• Super Micro Computer (SMCI) Falls 6%